Safe Orthopaedics enters into exclusive negotiations for the acquisition of LCI Medical

Nachrichtenquelle: globenewswire
06.05.2020, 18:00  |  159   |   |   

Safe Orthopaedics enters into exclusive negotiations for the acquisition of LCI Medical
                    

  • Establishment of an integrated player, leader in ready-to-use products for spinal surgery
  • Financial balance of the new organization targeted for the beginning of 2022
  • New growth and industrial partnerships opportunities

Éragny-sur-Oise, France, May 6 2020, 18h00 CET – Safe Orthopaedics (FR0013467123 – ALSAF), a company specializing in the design and marketing of ready-to use kits including implants and single-use instruments, new and sterile, for the mini-invasive surgery of spinal fracture, enters into exclusive negotiations for the acquisition of the medical device manufacturer LCI Médical (Fleurieux-sur-l’Arbresle, France).

Establishment of a leading group in the area of ready-to-use products

As an innovator and pioneer, Safe Orthopaedics has been the first actor to make available, for spinal surgeons, “ready-to-use” kits (implants and instruments) for spinal surgeries. With the adoption of this model in 24 countries and the growing demand, the company wishes to sustain its leadership position by incorporating the entire production value chain: conception, technology, production, distribution and hospital services.

As an historical and strategic supplier of Safe Orthopaedics, LCI Médical has shown its ability to industrialize high-quality implants and instruments, in line with specific constraints for the ready-to-use model. The company has two production sites, in France and in Tunisia. The company achieved a turnover of 2,6M€ in 2019 and displays a positive net result since its establishment. Its customers are medical device manufacturers in the spine, hip and maxillofacial surgery market. Safe Orthopaedics covers more than 30% of LCI Medical turnover.

The combination with LCI Médical will allow Safe Orthopaedics to deploy its expertise in other orthopaedic segments, through different channels: on its behalf, subcontracting and for third parties, as an original equipment manufacturer (OEM), or as part of co-development. LCI industrial facilities will be reinforced in order to meet the need of innovation of Safe Orthopaedics, but also to offer current LCI Médical customer new industrial services.

Seite 1 von 4
Safe Orthopaedics Aktie jetzt über den Testsieger (Finanztest 11/2020) handeln, ab 0 € auf Smartbroker.de



Diesen Artikel teilen

0 Kommentare

Schreibe Deinen Kommentar

Bitte melden Sie sich an, um zu kommentieren. Anmelden | Registrieren

 

Disclaimer

Safe Orthopaedics enters into exclusive negotiations for the acquisition of LCI Medical Safe Orthopaedics enters into exclusive negotiations for the acquisition of LCI Medical                      Establishment of an integrated player, leader in ready-to-use products for spinal surgery Financial balance of the new organization …

Meistgelesene Nachrichten des Autors

Titel
Titel
Titel
Titel